Neuro-Oncology Reviews
Volume
26 Number 11
15 June 2024
Home > Publications > Neuro-Oncology Reviews > Volume 26, Year 2024 > Number 11, 15 June
Khoury
JE, Wehbe S, Attieh F, Boutros M, Kesrouani C, Kourie HR.
A
critical review of RAF inhibitors in BRAF-mutated glioma
treatment.
Pharmacogenomics.
2024 Jun 3:1-13. doi:
10.1080/14622416.2024.2355859. PMID:
38884947. Review˰
ˍ
Pandey A, Chandla A, Mekonnen M, Hovis GEA, Teton ZE, Patel KS,
Everson RG, Wadehra M, Yang I.
Safety
and Efficacy of Laser Interstitial Thermal Therapy as Upfront
Therapy in Primary Glioblastoma and IDH-Mutant Astrocytoma: A
Meta-Analysis.
Cancers
(Basel). 2024 Jun 3;16(11):2131. doi:
10.3390/cancers16112131. PMID:
38893250.
Review. ˍ
Kotecha R, Schiff D, Chakravarti A, Fleming JL, Brown PD,
Puduvalli VK, Vogelbaum MA, Gondi V, Gallus M, Okada H, Mehta MP.
Multidisciplinary Management of
Isocitrate Dehydrogenase-Mutated Gliomas in a Contemporary
Molecularly Defined Era.
J
Clin Oncol. 2024 Jun 4:JCO2302195. doi:
10.1200/JCO.23.02195. PMID:
38833641. Review˰
ˍ
Picart T, Hervey-Jumper S.
Central
nervous system regulation of diffuse glioma growth and invasion:
from single unit physiology to circuit remodeling.
J
Neurooncol. 2024 Jun 4. doi:
10.1007/s11060-024-04719-x. PMID:
38834748. Review.
ˍ
*Ehara T, Ohka F, Motomura K, Saito R.
Epilepsy
in Patients with Gliomas.
Neurol
Med Chir (Tokyo). 2024 Jun 5. doi:
10.2176/jns-nmc.2023-0299. PMID:
38839295. Review.
ˍ
Magalhães M, Matias D, Carbone C, Cabral C.
Editorial:
Gliomas microenvironment: new drug entities, mechanisms of action,
molecular biomarkers and drug delivery strategies.
Front
Pharmacol. 2024 Jun 5;15:1431975. doi:
10.3389/fphar.2024.1431975. PMID:
38904005. Editorial. ˍ
Ritchey
AK
et
al., PDQ Pediatric Treatment Editorial Board.
Childhood
Ependymoma: Patient
Version.
PDQ
Cancer Inf Sum.
2024 Jun 5.
NCBI
Bookshelf ID:
NBK65742. PMID
26389185.
Review. ˍ
Sabri ME, Moghaddasi L, Wilson P, Saran F, Bezak E.
Targeted
Alpha Therapy for Glioblastoma: Review on In Vitro, In Vivo and
Clinical Trials.
Target
Oncol. 2024 Jun 5. doi:
10.1007/s11523-024-01071-y. PMID:
38836953. Review.
ˍ
Knittel R, Rogers S, Wood BA.
Cutaneous
Seeding of Glioblastoma: A Case Report and Literature Review.
Am
J Dermatopathol. 2024 Jun 6. doi:
10.1097/DAD.0000000000002748. PMID:
38842394. Case
report; Review˰ ˍ
White J, White MPJ, Wickremesekera A, Peng L, Gray C.
The
tumour microenvironment, treatment resistance and recurrence in
glioblastoma.
J
Transl Med. 2024 Jun 6;22(1):540. doi:
10.1186/s12967-024-05301-9. PMID:
38844944. Review.
ˍ
*Coronatto LH, Formentin C.
Palliative
care in glioblastoma patients: a systematic review.
Rev
Assoc Med Bras (1992). 2024 Jun 7;70(suppl
1):e2024S122. doi:
10.1590/1806-9282.2024S122. PMID:
38865542. Review.
ˍ
Onishi
S, Yamasaki F, Kinoshita Y, Amatya VJ, Yonezawa U, Taguchi A,
Ozono I, Maeda Y, Khairunnisa NI, Go Y, Takeshima Y, Horie N.
Characteristics
of radiation-induced brain tumors: case series and systematic
review.
J
Neurosurg.
2024 Jun 7:1-9. doi:
10.3171/2024.3.JNS232934. PMID:
38848603. Case report; Review. ˍ
Ter
Linden E, Abels ER, van Solinge TS, Neefjes J, Broekman MLD.
Overcoming
Barriers in Glioblastoma-Advances in Drug Delivery Strategies.
Cells.
2024 Jun 7;13(12):998. doi:
10.3390/cells13120998. PMID:
38920629.
Review. ˍ
Kumar S, Arwind DA, Kumar B H, Pandey S, Nayak R, Vithalkar MP,
Kumar N, Pai KSR.
Inhibition of STAT3:
A promising approach to enhancing the efficacy of chemotherapy in
medulloblastoma.
Transl
Oncol. 2024 Jun 8;46:102023. doi:
10.1016/j.tranon.2024.102023. PMID:
38852276. Review.
ˍ
Peterson K, Turos-Cabal M, Salvador AD, Palomo I, Howell AJ,
Vieira ME, Greiner SM, Barnoud T, Rodriguez-Blanco J.
Mechanistic
insights into medulloblastoma relapse.
Pharmacol
Ther. 2024 Jun 8:108673. doi:
10.1016/j.pharmthera.2024.108673. PMID:
38857789. Review.
ˍ
Posey AD Jr, Young RM, June CH.
Future
perspectives on engineered T cells for cancer.
Trends
Cancer. 2024 Jun 8:S2405-8033(24)00097-9. doi:
10.1016/j.trecan.2024.05.007. PMID:
38853073. Review.
ˍ
Shehaj A, Khristov V, Mareboina M, Tufano E, Abdeen A, Rizk E,
Connor J.
Genetic Biomarkers in
Astrocytoma: Diagnostic, Prognostic, and Therapeutic Potential.
World
Neurosurg. 2024 Jun 8:S1878-8750(24)00955-0. doi:
10.1016/j.wneu.2024.06.009. PMID:
38857866. Review˰
ˍ
Salvalaggio A, Pini L, Bertoldo A, Corbetta M.
Glioblastoma
and brain connectivity: the need for a paradigm shift.
Lancet
Neurol. 2024 Jun 12;23(7):740-748. doi:
10.1016/S1474-4422(24)00160-1. PMID:
38876751. Perspective˰
ˍ
Stefan
H, Bösebeck F, Rössler K.
Brain
tumor-associated epilepsies in adulthood: Current state of
diagnostic and individual treatment options.
Seizure.
2024 Jun 8:S1059-1311(24)00161-4. doi:
10.1016/j.seizure.2024.06.004. PMID:
38910076. Review˰
ˍ
Zhang
H, Hong Y, Wu T, Ben E, Li S, Hu L, Xie T.
Role
of gut microbiota in regulating immune checkpoint inhibitor
therapy for glioblastoma.
Front
Immunol.
2024 Jun 10;15:1401967. doi:
10.3389/fimmu.2024.1401967. PMID:
38915399.
Review. ˍ
Squalli
Houssaini A, Lamrabet S, Nshizirungu JP, Senhaji N, Sekal M,
Karkouri M, Bennis S.
Glioblastoma
Vaccines as Promising Immune-Therapeutics: Challenges and Current
Status.
Vaccines
(Basel).
2024 Jun 12;12(6):655. doi:
10.3390/vaccines12060655. PMID:
38932383.
Review. ˍ
Yuen CA, Pekmezci M, Bao S, Kong XT.
Metastatic
glioblastoma to the lungs: a case report and literature review.
CNS
Oncol. 2024 Jun 12;13(1):2351789. doi:
10.1080/20450907.2024.2351789. PMID:
38864820.
Case report; Review. ˍ
Valenzuela-Fuenzalida
JJ, Moyano-Valarezo L, Silva-Bravo V, Milos-Brandenberg D,
Orellana-Donoso M, Nova-Baeza P, Suazo-Santibáñez A,
Rodríguez-Luengo M, Oyanedel-Amaro G, Sanchis-Gimeno J,
Gutiérrez Espinoza H.
Association
between the Anatomical Location of Glioblastoma and Its Evaluation
with Clinical Considerations: A Systematic Review and
Meta-Analysis.
J
Clin Med.
2024 Jun 13;13(12):3460. doi:
10.3390/jcm13123460. PMID:
38929990. Review; Meta-analysis. ˍ
Holzgreve
A, Nitschmann A, Maier SH, Büttner M, Schönecker S,
Marschner SN, Fleischmann DF, Corradini S, Belka C, la Fougère
C, Bodensohn R, Albert NL, Niyazi M.
FET
PET-based target volume delineation for the radiotherapy of
glioblastoma: A pictorial guide to help overcome methodological
pitfalls.
Radiother
Oncol.
2024 Jun 14:110386. doi:
10.1016/j.radonc.2024.110386. PMID:
38880414. Guidelines. ˍ
Siegel BI, Duke ES, Kilburn LB, Packer RJ.
Molecular-targeted
therapy for childhood low-grade glial and glioneuronal tumors.
Childs
Nerv Syst. 2024 Jun 15. doi:
10.1007/s00381-024-06486-6. PMID:
38877124. Perspective˰
ˍ